Otros idiomas PolyNovo Limited

Acciones

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:52 20/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2,07 ^AUD	-0,48 %		-7,17 %	+25,08 %

08/05	Los ingresos de PolyNovo suben un 68,6% en abril	MT
04/03	Polynovo obtiene el visto bueno de la India para incluir su dispositivo de andamiaje dérmico en el mercado del portal electrónico del Gobierno	MT

PolyNovo's Revenue Climbs 68.6% in April	08/05
Polynovo Gets India OK for Listing of Dermal Scaffold Device on Government e-Portal Marketplace	04/03
PolyNovo Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
PolyNovo Secures Largest Single Order Worth AU$1.2 Million; Shares Rise 3%	16/02
MÄRKTE ASIEN/Zurückhaltung vor Fed-Entscheid - Tankan-Bericht stützt Tokio	13/12
Ord Minnett rates PNV as Lighten	08/12
PolyNovo Logs Record Monthly Sales in November	06/12
PolyNovo Limited Reports Unaudited Sales Results for the Month of November 2023	06/12
Polynovo Secures Additional Funding from BARDA for Burn Treatment Trial	02/10/23
PolyNovo Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23/08/23
Immuron Appoints Paul Brennan as Board Chairman	30/06/23
PolyNovo Limited Reports Revenue Results for the Month and Nine Months Ended 31 March 2023	02/05/23
PolyNovo Limited(ASX:PNV) added to S&P/ASX 200 Index	20/03/23
Polynovo Swings to Net Loss in Fiscal H1 on Employee, R&D Expansion; Shares Fall 4%	24/02/23
PolyNovo Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23
PolyNovo Limited Announces Update on SynPath Diabetic Foot Ulcer Trial	14/02/23
PolyNovo Limited Provides Unaudited Revenues Results for the First Half 2023	15/01/23
Polynovo to Raise AU$20 Million from Share Purchase Plan	16/12/22
Polynovo Kicks Off $11 Million Share Offering	30/11/22
PolyNovo to Raise $20 Million in Institutional Placement; Shares Slip 9%	23/11/22

No hay resultados para esta búsqueda